A Case Report of Recurrent L858R Mutation Non-Small-Cell Lung Cancer with Brain Metastases Treated with Erlotinib and Traditional Korean Medicine After Failure with Gefitinib
Article in The Journal of Internal Korean Medicine (October 2022)
The most recent citing publications are shown below. View all 8 publications that cite this research output on Dimensions.
Erlotinib as a salvage treatment after gefitinib failure for advanced non-small-cell lung cancer patients with brain metastasis
Article in Medicine (June 2021)
Chemotherapy should be performed in epidermal growth factor receptor mutation-positive lung adenocarcinoma patients who had progressive disease to the first epidermal growth factor receptor-tyrosine kinase inhibitor.
Article in Anti-Cancer Drugs (September 2020)